Drugmakers and employers are hopeful that the GOP's plan to repeal the ACA will elimninate the Branded Prescription Drug Fee — an excise tax on brand name medications, reports The Hill.
Supply Chain
Martin Shkreli, former CEO of Turing Pharmaceuticals, is targeting the drug industry with a new website highlighting the major issues of individual drugmakers, reports STAT News.
The Food and Drug Administration granted priority review designation for Roche's rheumatoid arthritis drug Actemra, reports Reuters.
The Food and Drug Administration recently approved a new indication for the drug Imbruvica.
President Donald Trump met with a group of Fortune 500 CEOs at the White House Monday and warned them that any move to shift manufacturing processes overseas will be met with a "substantial border tax," reports CNN.
Advertisement
The Florida Department of Health on Friday sent an email to pharmacists warning them of potential prescription drug shortages in the state due to recent sanctions taken against the wholesale drug distributor McKesson Corp., reports Pain News Network.
President Donald Trump signed an executive order Monday formally withdrawing the U.S. from the Trans-Pacific Partnership — a trade agreement to lower or eliminate tariffs between the U.S. and 11 other countries, reports NBC News.
The pharmaceutical industry's major lobbying group has launched its largest-ever ad campaign designed to improve the industry's public image following heated criticism over rising drug prices and President Donald Trump's comments in a January press conference, in which he said…
During the JPMorgan Healthcare Conference in San Francisco this month, Business Insider posed a hypothetical question to drug company executives: How would your job be affected if annual — or sometimes biannual — price hikes were not standard practice?
President Donald Trump plans to tackle high drug prices through his ACA replacement, White House press secretary Sean Spicer said during a Monday press briefing.